4.6 Review

Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice

Josiah E. E. Hardesty et al.

Summary: Alcohol-associated liver disease (ALD) is a major health issue with limited treatment options. Alcohol-associated hepatitis (AH) is a severe form of ALD and has a high mortality rate. This study investigated the therapeutic efficacy and mechanisms of Resolvin D1 (RvD1) in treating liver injury and inflammation in an animal model of severe AH.

FASEB JOURNAL (2023)

Article Toxicology

20-Hydroxytetraenoic acid induces hepatic fibrosis via the TGF-131/Smad3 signaling pathway

Biao Li et al.

Summary: This study found that 20-HETE plays an important role in hepatic fibrosis. Higher levels of 20-HETE were observed in patients with hepatic fibrosis and were closely related to the degree of fibrosis. 20-HETE could induce activation of hepatic stellate cells and promote hepatic fibrosis through the TGF-beta 1/Smad3 signaling pathway. Inhibition of 20-HETE production could attenuate hepatic fibrosis.

TOXICOLOGY LETTERS (2023)

Article Gastroenterology & Hepatology

Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme

Dandan Zhong et al.

Summary: mPGES-2 plays a crucial role in the development of NAFLD by regulating the processes of hepatic lipid accumulation, inflammation, and fibrosis through modulating cytochrome P450 4A14 and acyl-CoA thioesterase 4. The study highlights the therapeutic potential of mPGES-2 inhibition in liver steatosis and steatohepatitis.

HEPATOLOGY (2023)

Article Pharmacology & Pharmacy

Efruxifermin, a long-acting Fc-fusion FGF21 analogue, reduces body weight gain but does not increase sympathetic tone or urine volume in Sprague Dawley rats

Erik J. Tillman et al.

Summary: Efruxifermin is an FGF21 analogue that can reduce weight gain and decrease urine volume without increasing sympathetic tone.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Immunology

Resolvin D1 ameliorates hepatic steatosis by remodeling the gut microbiota and restoring the intestinal barrier integrity in DSS-induced chronic colitis

Cui Zeng et al.

Summary: This study found that RVD1 alleviates DSS-induced hepatic steatosis by improving intestinal barrier function and modulating intestinal dysbiosis.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair

David Meriwether et al.

Summary: The study indicates that macrophage COX2 can enhance efferocytosis capacity and efferocytosis-dependent reprogramming, promoting intestinal epithelial repair.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway

Ying Cao et al.

Summary: The study found that in the progression of nonalcoholic fatty liver disease, liver macrophages polarized towards M2 type and promoted HSC autophagy by secreting PGE2, worsening liver fibrosis. The PGE2/EP4 pathway may be a promising therapeutic target to prevent NASH progression into cirrhosis.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Gastroenterology & Hepatology

CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase

Yuli Lin et al.

Summary: This study demonstrates that cancer-associated fibroblasts (CAFs) promote cancer stemness by regulating myeloid-derived suppressor cells (MDSCs) in intrahepatic cholangiocarcinoma (ICC). The 5-LO/LTB4-BLT2 axis may serve as promising therapeutic targets for overcoming ICC chemoresistance by targeting cancer stemness.

HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylami-nofluorene-Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling

Gaber Ali et al.

Summary: This study aimed to investigate the chemopreventive effect of etoricoxib on DENA/2AAF-induced HCC in male Wistar rats. The results demonstrated that etoricoxib possesses an anticancer effect through its antioxidant, anti-inflammatory, and modulation of NF-KB/COX-2/PGE2 signaling.

CURRENT MOLECULAR PHARMACOLOGY (2022)

Article Nutrition & Dietetics

Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells

Nazek Noureddine et al.

Summary: Through the study of mouse models and human cells, it was found that lipid emulsions rich in n-3 PUFA have more favorable clinical outcomes in total parenteral nutrition, which is associated with the generation of lipid mediators, especially SPMs and endocannabinoids in the spleen.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

Review Virology

Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis

Tania Guadalupe Heredia-Torres et al.

Summary: Viral infection-induced cancer is a major cause of cancer development, with HCV being a virus that causes chronic liver infection. The virus promotes liver cancer development through various molecular mechanisms, but recent treatments with DAAs have also shown an increased risk of early HCC occurrence in some cases. Therefore, a better understanding of molecular mechanisms and therapeutic targets is crucial.

VIRUSES-BASEL (2022)

Article Cell Biology

Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt-dependent lipogenic pathway

Cong Zhang et al.

Summary: Mounting evidence suggests that hepatic de novo lipogenesis is common in patients with non-alcoholic fatty liver disease (NAFLD). This study investigates the potential of the selective COX-2 inhibitor, celecoxib, to alleviate hepatic steatosis by targeting an Akt-driven lipogenic pathway. The results show that celecoxib effectively suppresses Akt/mTORC1 signaling and its downstream lipogenic cascade, thereby ameliorating hepatic steatosis in Akt-triggered NAFLD mice. However, its efficacy is limited in fructose-fed NAFLD mice.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Article Pharmacology & Pharmacy

Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress

Heeseung Oh et al.

Summary: This study found that RD3 alleviates insulin resistance in skeletal muscle and hepatic steatosis through the AMPK/autophagy signaling pathway, providing a new therapeutic approach for treating metabolic disorders.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis

You Lan et al.

Summary: This study reveals the mechanism by which HBx protein causes imbalanced macrophage polarization, leading to NASH. It provides a basis for screening potential biomarkers and evaluating interventions for HBx-associated NASH.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

Linchao Ding et al.

Summary: The study reveals that hepatocellular carcinoma and intrahepatic cholangiocarcinoma share common interrupted pathways related to fatty acid, retinol, and arachidonic acid metabolism, indicating similarities in pathogenesis. However, they also possess distinctive promising biomarkers for predicting overall survival or potential targeted therapies.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Nutrition & Dietetics

Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients-Randomized Control Trials (RCT)

Dominika Maciejewska-Markiewicz et al.

Summary: This study analyzed the changes in fatty acids and eicosanoids in the serum of participants who consumed high-fiber rolls for 8 weeks. The results showed that a high amount of dietary fiber was associated with a reduction in fatty liver. Regardless of the amount of fiber consumed, significant changes in the profile of fatty acids and eicosanoids were observed, reflecting positive changes in liver metabolism.

NUTRIENTS (2022)

Article Clinical Neurology

Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia

Brandon Ebright et al.

Summary: This study compared the lipidome in the dorsolateral prefrontal cortex of older individuals with AD dementia and age-matched controls with no cognitive impairment. The results showed lower levels of neuroprotectin D1 and omega-3 fatty acids in AD dementia patients, which were associated with lower cognitive function. Carrying the APOE4 allele was found to be associated with higher levels of pro-inflammatory and pro-resolving eicosanoid lipids. Furthermore, the activation of certain enzymes involved in lipid metabolism pathways was observed. These findings highlight the role of the eicosanoid lipidome in chronic inflammation in AD dementia and suggest potential therapeutic targets.

ALZHEIMERS RESEARCH & THERAPY (2022)

Review Oncology

Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis

Taojian Tu et al.

Summary: Obesity is independently associated with an increased risk of carcinogenesis, particularly liver cancer. Liver lipid dysfunction and inflammation, as well as the involvement of liver macrophages, play crucial roles in driving the progression of liver cancer. Specific inflammatory mediators and molecular signals related to lipid metabolism are also involved in the activation and reprogramming of liver macrophages, contributing to the development of liver cancer.

FRONTIERS IN ONCOLOGY (2022)

Article Medicine, General & Internal

Influence of Lipoxin-A4 Treatment on Cytokine, Chemokine Genes Expression, and Phenotypic Distribution of Lymphocyte Subsets During Experimental Liver Fibrosis

Zeynal Mete Karaca et al.

Summary: Lipoxin A4 exerts its anti-inflammatory effects by reducing the frequency of activated T cells and decreasing the expression levels of chemokines and cytokines responsible for inflammatory immune response in the liver.

EURASIAN JOURNAL OF MEDICINE (2022)

Article Endocrinology & Metabolism

Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution

Patrick B. Ampomah et al.

Summary: This study demonstrates that methionine derived from apoptotic cells taken up by macrophages during efferocytosis plays a role in mediating tissue resolution by providing a substrate for DNA methylation and repressing the expression of the ERK1/2 phosphatase Dusp4, leading to activation of ERK1/2 and the expression of pro-resolving mediators.

NATURE METABOLISM (2022)

Review Pharmacology & Pharmacy

Carcinogenesis: Failure of resolution of inflammation

Anna Fishbein et al.

Summary: Inflammation in the tumor microenvironment is a hallmark of cancer and is recognized as a key characteristic of carcinogens. The failure of resolution of inflammation in cancer is being understood. Eicosanoids play a critical role in regulating inflammation and its resolution, while non-genotoxic mechanisms such as inflammation and oxidative stress promote genotoxicity and contribute to carcinogenesis.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Cytochrome P450 2A6 is associated with macrophage polarization and is a potential biomarker for hepatocellular carcinoma

Tao Jiang et al.

Summary: Cytochrome P450 2A6 is downregulated in hepatocellular carcinoma and its reduced expression leads to alternative activation of macrophage polarization. The disruption of 20-HETE and EETs equilibrium induced by CYP2A6 contributes to macrophage polarization and modulation of antitumor immunity.

FEBS OPEN BIO (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor Microenvironment

Tiange Dong et al.

Summary: NAP1051, a biomimetic of LXA4, demonstrated LXA4-like properties and antitumor activity in colorectal cancer models by modulating neutrophils and NETosis. It inhibited neutrophil chemotaxis and promoted dTHP-1 efferocytosis, showing potential as a therapeutic agent for colorectal cancer. Moreover, NAP1051 significantly reduced tumor growth in mouse xenograft models by reducing neutrophil and myeloid-derived suppressor cell populations in the TME.

MOLECULAR CANCER THERAPEUTICS (2021)

Review Biochemistry & Molecular Biology

Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence

Julianne M. Thornton et al.

Summary: Host response to bacterial infection involves leukocyte activation, inflammatory mediator release, phagocytosis, and killing of bacteria, while resolution of infection requires attenuation of neutrophil migration, neutrophil apoptosis, and other processes. Specialized Pro-resolving Mediators (SPMs) are bioactive fatty acids that play a critical role in promoting the resolution of infectious inflammation and bacterial clearance, including a novel mechanism of reducing bacterial virulence.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway

Da Tang et al.

Summary: The study demonstrated that MaR1 can protect the liver against hepatic ischemia/reperfusion injury through the ALXR/Akt signaling pathway. MaR1 treatment significantly reduces liver injury, suppresses inflammatory responses, oxidative stress, and decreases hepatocyte apoptosis.

MOLECULAR MEDICINE (2021)

Article Pharmacology & Pharmacy

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis

Shiyun Pu et al.

Summary: The study revealed that 5-LO plays a critical role in activating HSC and liver fibrosis, and genetic ablation or pharmacological inhibition of 5-LO can improve liver fibrosis induced by certain factors.

FRONTIERS IN PHARMACOLOGY (2021)

Article Pathology

Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis

Chien-Yu Chen et al.

Summary: Inhibiting ERR alpha can block the development of NAFLD, reduce lipid accumulation, and attenuate NASH. Glycerolipid synthesis was identified as an additional mechanism for ERR alpha-regulated NAFLD/NASH development, with glycerophosphate acyltransferase 4 identified as a novel transcriptional target of ERR alpha. These results establish ERR alpha as a potential target for NAFLD/NASH treatment and highlight novel signaling pathways regulated by ERR alpha.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Medicine, Research & Experimental

Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma

Filippo Pelizzaro et al.

Summary: The study revealed the activation of the MAGL/COX-2/PGE2 axis in hepatocellular carcinoma, with circulating PGE2 serving as a potential prognostic biomarker in HCC patients. Elevated levels of circulating PGE2 were associated with significantly shorter overall survival in HCC patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway

Jiahuan Li et al.

Summary: The study demonstrated that RvD1 effectively reduced liver injury and fibrosis induced by CCl4 in mice by inhibiting pro-fibrotic gene expression and restoring damaged histological architecture. In vitro, RvD1 suppressed LX-2 cell activation and proliferation. Additionally, RvD1 exerted its protective effects by inhibiting autophagy in hepatic stellate cell activation, partly through the AKT/mTOR pathway.

FRONTIERS IN PHARMACOLOGY (2021)

Article Cell Biology

Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation

Maria Jose Rodriguez et al.

Summary: Treatment with MaR1 significantly improved liver function in an animal model of DEN-induced liver fibrosis, reducing inflammation and necrosis, promoting hepatocyte proliferation, decreasing oxidative stress, and modulating the NF-kappa B and Nrf2 pathways positively.
Review Biochemistry & Molecular Biology

Regulation of Tissue Inflammation by 12-Lipoxygenases

Abhishek Kulkarni et al.

Summary: 12-LOX is a key lipid metabolizing enzyme that plays an important role in inflammatory diseases. Increased activity of 12-LOX can lead to tissue damage and enhanced migration of immune cells, while inhibition of this enzyme can protect against disease development and progression in animal models.

BIOMOLECULES (2021)

Article Immunology

A subset of Kupffer cells regulates metabolism through the expression of CD36

Camille Bleriot et al.

Summary: The study shows that tissue macrophages in the murine liver (KCs) have more subpopulations, with one of them being associated with metabolic functions. Depletion of this subpopulation leads to increased liver oxidative stress, especially in obesity.

IMMUNITY (2021)

Review Immunology

Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections

Austin E. F. Sheppe et al.

Summary: Eicosanoids are lipid-based signaling molecules that play a crucial role in innate immune responses, with prostaglandins and leukotrienes helping immune cells combat bacterial invasions rapidly. Bacterial pathogens alter the expression of eicosanoid-specific biosynthetic enzymes to interfere with host responses to bacteria.

INFECTION AND IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study

Xia Fang et al.

Summary: A cross-sectional study found that circulating MaR1 levels were significantly lower in NAFLD patients compared to non-NAFLD subjects, and the percentage of NAFLD patients decreased with increasing MaR1 levels. Additionally, MaR1 levels were correlated with various blood and biochemical markers.

LIPIDS IN HEALTH AND DISEASE (2021)

Review Urology & Nephrology

Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function

Eoin Brennan et al.

Summary: Obesity, diabetes mellitus, hypertension, and cardiovascular disease are risk factors for chronic kidney disease and kidney failure. Inflammation is a known driver of diabetes and obesity-associated kidney disease. The discovery of endogenously generated lipid mediators that promote the resolution of inflammation offers novel opportunities for therapeutic intervention.

NATURE REVIEWS NEPHROLOGY (2021)

Article Multidisciplinary Sciences

Transformation of SOX9+ cells by Pten deletion synergizes with steatotic liver injury to drive development of hepatocellular and cholangiocarcinoma

Jingyu Chen et al.

Summary: The research indicates that SOX9(+) cells play a crucial role in liver carcinogenesis, and the loss of gene PTEN induces the transformation of these cells. Liver injury is crucial for promoting the activation and proliferation of transformed SOX9(+) cells.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation

Ryan G. Snodgrass et al.

Summary: The study identified a mechanism whereby macrophages selectively upregulate anti-inflammatory and proresolving genes when exposed to apoptotic cells or LXR agonists and Th2 cytokines, enhancing inflammation resolution and tissue repair.

CELL DEATH AND DIFFERENTIATION (2021)

Article Medicine, Research & Experimental

Dual-Specific Protein and Lipid Phosphatase PTEN and Its Biological Functions

Taojian Tu et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)

Article Gastroenterology & Hepatology

Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease

Qian Li et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Article Biochemistry & Molecular Biology

Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling

Peng Zhang et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

Review Gastroenterology & Hepatology

Epidemiology and surveillance for hepatocellular carcinoma: New trends

Amit G. Singal et al.

JOURNAL OF HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C

Sudeep Tanwar et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Article Biochemistry & Molecular Biology

Cytochrome P450-derived eicosanoids and inflammation in liver diseases

Sherif M. Shoieb et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2020)

Article Biochemistry & Molecular Biology

The regulatory mechanism involved in the prostaglandin E2 disposition in carbon tetrachloride-induced liver injury

Hiroaki Shimada et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2020)

Article Pharmacology & Pharmacy

Regulation of liver regeneration by prostaglandin E2and thromboxane A2following partial hepatectomy in rats

Yasmin S. Mohamed et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

Klaudia Sztolsztener et al.

BIOMOLECULES (2020)

Article Biochemistry & Molecular Biology

Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease

Margalida Monserrat-Mesquida et al.

ANTIOXIDANTS (2020)

Article Gastroenterology & Hepatology

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis

Cyrielle Caussy et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)

Article Biochemistry & Molecular Biology

Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade

Zhenpeng Qiu et al.

MOLECULAR CARCINOGENESIS (2019)

Review Immunology

Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis

Tomoaki Ishihara et al.

INTERNATIONAL IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis

Yong-Hyun Han et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Biochemistry & Molecular Biology

BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system

Qiong-Feng Chen et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)

Article Gastroenterology & Hepatology

Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease

Bei Gao et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Food Science & Technology

Maresin 1 Regulates Hepatic FGF21 in Diet-Induced Obese Mice and in Cultured Hepatocytes

L. Martinez-Fernandez et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2019)

Article Oncology

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

Indu Ramachandran et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Article Multidisciplinary Sciences

Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy

Florencia Lorenzetti et al.

SCIENTIFIC REPORTS (2019)

Article Endocrinology & Metabolism

Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice

L. M. Laiglesia et al.

INTERNATIONAL JOURNAL OF OBESITY (2018)

Article Agriculture, Multidisciplinary

Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A2 Pathway

Wenzhe Wang et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway

Tae Woo Jung et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells

Sang-Kyu Park et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Review Immunology

Immune Responses in the Liver

Paul Kubes et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

Article Gastroenterology & Hepatology

Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice

Nobuyuki Nishizawa et al.

JOURNAL OF HEPATOLOGY (2018)

Review Medicine, Research & Experimental

Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review

Ramesh Kumar Saini et al.

LIFE SCIENCES (2018)

Article Biochemistry & Molecular Biology

20-HETE regulated PSMB5 expression via TGF-β/Smad signaling pathway

Guangrui Lai et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2018)

Article Multidisciplinary Sciences

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux

Cong Liu et al.

SCIENTIFIC REPORTS (2018)

Article Oncology

Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma

Hyuk Soo Eun et al.

MOLECULAR MEDICINE REPORTS (2018)

Article Multidisciplinary Sciences

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations

Sonya A. MacParland et al.

NATURE COMMUNICATIONS (2018)

Review Immunology

Innate Immune Cells in Immune Tolerance After Liver Transplantation

Hongting Huang et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Gastroenterology & Hepatology

Role of inflammatory response in liver diseases: Therapeutic strategies

Jose A. Del Campo et al.

WORLD JOURNAL OF HEPATOLOGY (2018)

Article Biochemistry & Molecular Biology

BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats

Quandong Hu et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)

Article Biochemistry & Molecular Biology

Prostaglandin I2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice

Shima Kumei et al.

FASEB JOURNAL (2017)

Article Multidisciplinary Sciences

Dormant 5-lipoxygenase in inflammatory macrophages is triggered by exogenous arachidonic acid

Carlos A. Sorgi et al.

SCIENTIFIC REPORTS (2017)

Article Cardiac & Cardiovascular Systems

20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension

Victor Garcia et al.

CIRCULATION RESEARCH (2017)

Article Gastroenterology & Hepatology

Crosstalk of LKB1-Regulated and PTEN-Regulated Signals in Liver Morphogenesis and Tumor Development in Mice

Chengyou Jia et al.

HEPATOLOGY COMMUNICATIONS (2017)

Article Pharmacology & Pharmacy

Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity

Shiyun Pu et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Suppressing Cyclooxygenase-2 Prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway

Jialing Wu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis

Jung-Woo Kang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Article Cell Biology

Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1

Olga A. Smirnova et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Article Cell Biology

Activation of hepatic stellate cell in Pten null liver injury model

Lina He et al.

FIBROGENESIS & TISSUE REPAIR (2016)

Article Biochemistry & Molecular Biology

BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats

Dan Yan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Biochemistry & Molecular Biology

Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors

Kohichi Kawahara et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)

Article Gastroenterology & Hepatology

Liver inflammation abrogates immunological tolerance induced by Kupffer cells

Felix Heymann et al.

HEPATOLOGY (2015)

Article Immunology

Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats

Tao Zhang et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2015)

Article Biochemistry & Molecular Biology

The role of lipoxygenases in pathophysiology; new insights and future perspectives

Ryuichi Mashima et al.

REDOX BIOLOGY (2015)

Article Gastroenterology & Hepatology

Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet

Magda Hamzawy et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Natural history of hepatitis C

Rachel H. Westbrook et al.

JOURNAL OF HEPATOLOGY (2014)

Article Biochemistry & Molecular Biology

Protective effects of BML-111 against acetaminophen-induced acute liver injury in mice

Dina S. El-Agamy et al.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2014)

Article Substance Abuse

Thromboxane Inhibitors Attenuate Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administrations

Amin A. Nanji et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)

Article Pathology

Distinct responses of lung and liver macrophages to acute endotoxemia Role of toll-like receptor 4

Agnieszka J. Connor et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)

Article Medicine, Research & Experimental

Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers

Mark op den Winkel et al.

LABORATORY INVESTIGATION (2013)

Article Cell Biology

Tissue damage detection by osmotic surveillance

Balazs Enyedi et al.

NATURE CELL BIOLOGY (2013)

Article Biotechnology & Applied Microbiology

5-Lipoxygenase Deficiency Reduces Acetaminophen-Induced Hepatotoxicity and Lethality

Miriam S. N. Hohmann et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Biochemistry & Molecular Biology

Role of ErbB2 in the prostaglandin E2-induced enhancement of the mitogenic response to epidermal growth factor in cultured hepatocytes

John Odegard et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Article Biochemistry & Molecular Biology

Lipid metabolism enzyme 5-LOX and its metabolite LTB4 are capable of activating transcription factor NF-κB in hepatoma cells

Yu Zhao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Article Gastroenterology & Hepatology

Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis

Naoki Tanaka et al.

HEPATOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases

Eva H. C. Tang et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)

Article Oncology

Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells

Ingun Heiene Tveteraas et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)

Review Immunology

Regulation of Immune Responses by Prostaglandin E-2

Pawel Kalinski

JOURNAL OF IMMUNOLOGY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Pharmacology & Pharmacy

Activation of the Acute Inflammatory Response Alters Cytochrome P450 Expression and Eicosanoid Metabolism

Katherine N. Theken et al.

DRUG METABOLISM AND DISPOSITION (2011)

Article Biochemistry & Molecular Biology

Signaling via Macrophage G2A Enhances Efferocytosis of Dying Neutrophils by Augmentation of Rac Activity

S. Courtney Frasch et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Oncology

5-Lipoxygenase contributes to the progression of hepatocellular carcinoma

Xi-Ming Xu et al.

MOLECULAR MEDICINE REPORTS (2011)

Article Pharmacology & Pharmacy

Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1

Ana-Cristina Dragomir et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)

Article Oncology

Circulating LTD4 in patients with hepatocellular carcinoma

Yan Zhou et al.

TUMOR BIOLOGY (2011)

Article Medicine, Research & Experimental

Suppressive action of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice

Taisuke Murakami et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)

Article Pathology

The Critical Role of AKT2 in Hepatic Steatosis Induced by PTEN Loss

Lina He et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Review Oncology

Cytochrome P450-derived eicosanoids: the neglected pathway in cancer

Dipak Panigrahy et al.

CANCER AND METASTASIS REVIEWS (2010)

Article Medicine, General & Internal

Population-based risk factors and resource utilization for HCC: US perspective

A. Sanyal et al.

CURRENT MEDICAL RESEARCH AND OPINION (2010)

Article Medicine, Research & Experimental

Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells

Xiao-Ming Bai et al.

LIFE SCIENCES (2010)

Review Nutrition & Dietetics

Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids

Rebecca Wall et al.

NUTRITION REVIEWS (2010)

Article Multidisciplinary Sciences

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Sriram Krishnamoorthy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Gastroenterology & Hepatology

mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC

Koichi Nonaka et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Review Pharmacology & Pharmacy

Lipoxins: resolutionary road

Paola Maderna et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice

Jonathan M. Gitlin et al.

CARDIOVASCULAR RESEARCH (2009)

Article Immunology

Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling

Alexandra I. Medeiros et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Endocrinology & Metabolism

12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes

Swarup K. Chakrabarti et al.

OBESITY (2009)

Article Gastroenterology & Hepatology

Mechanism of T cell tolerance induction by murine hepatic Kupffer cells

Qiang You et al.

HEPATOLOGY (2008)

Review Biochemistry & Molecular Biology

Human biochemistry of the isoprostane pathway

Ginger L. Milne et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Oncology

Differential expression of E-prostanoid receptors in human hepatocellular carcinoma

Marco Breinig et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Article Pharmacology & Pharmacy

20-hydroxyeicosatetraenoic acid stimulates nuclear factor-kappa B activation and the production of inflammatory cytokines in human endothelial cells

Tsuneo Ishizuka et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Gastroenterology & Hepatology

Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2

Christian J. Steib et al.

JOURNAL OF HEPATOLOGY (2007)

Article Biochemistry & Molecular Biology

Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells

Amalia Fernandez-Martinez et al.

BIOCHEMICAL JOURNAL (2006)

Article Pharmacology & Pharmacy

Liver disease selectively modulates cytochrome P450-mediated metabolism

Reginald F. Frye et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)

Article Biochemistry & Molecular Biology

COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages

Y Bezugla et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)

Article Oncology

Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats

Laura C. Smith et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)

Review Environmental Sciences

Lipoxins and annexin-1: Resolution of inflammation and regulation of phagocytosis of apoptotic cells

Michael Scannell et al.

THESCIENTIFICWORLDJOURNAL (2006)

Review Surgery

Role of thromboxane in producing hepatic injury during hepatic stress

Y Yokoyama et al.

ARCHIVES OF SURGERY (2005)

Article Multidisciplinary Sciences

Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity

B Stiles et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Gastroenterology & Hepatology

Role of thromboxane A2 in early BDL-induced portal hypertension

Y Yokoyama et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)

Article Biochemistry & Molecular Biology

Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor

K Takayama et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Chemistry, Medicinal

A protective role for cyclooxygenase-2 in drug-induced liver injury in mice

TP Reilly et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2001)